660
Views
77
CrossRef citations to date
0
Altmetric
Reviews

The administration of l-thyroxine as soft gel capsule or liquid solution

, MD, , MD, , MD & , MD

Bibliography

  • Garber JR, Cobin RH, Gharib H, et al. American Association of Clinical Endocrinologists and American Thyroid Association Task Force on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18(6):988-1028
  • Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev 2014. [ Epub ahead of print]
  • Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214
  • Pacini F, Castagna MG. Approach to and treatment of differentiated thyroid carcinoma. Med Clin North Am 2012;96:369-83
  • Antonelli A, Fallahi P, Ferrari SM, et al. Dedifferentiated thyroid cancer: a therapeutic challenge. Biomed Pharmacother 2008;62:559-63
  • Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab 2012;97:1134-45
  • Kendall EC. Landmark article, June 19, 1915 The isolation in crystalline form of the compound containing iodine, which occurs in the thyroid. Its chemical nature and physiologic activity. JAMA 1983;250:2045-6
  • Lindholm J, Laurberg P. Hypothyroidism and thyroid substitution: historical aspects. J Thyroid Res 2011;2011:809341
  • Braverman LE, Ingbar SH, Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest 1970;49:855-64
  • Bunevicius R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-9
  • Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005;90:2666-74
  • Clyde PW, Harari AE, Getka EJ, et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 2003;290:2952-8
  • Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, et al. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005;142:412-24
  • Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA Guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 2012;1:55-71
  • Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab 2012;97:2256-71
  • Eadala P, Waud JP, Matthews SB, et al. Quantifying the ‘hidden’ lactose in drugs used for the treatment of gastrointestinal conditions. Aliment Pharmacol Ther 2009;29:677-87
  • Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006;354:1787-95
  • Hays MT, Nielsen RK. Human thyroxine absorption: age effects and methodological analyses. Thyroid 1994;4:55-64
  • Benvenga S, Bartolone L, Squadrito S, et al. Delayed intestinal absorption of levothyroxine. Thyroid 1995;5:249-53
  • Hays MT. Localization of human thyroxine absorption. Thyroid 1991;1:241-8
  • Walter-Sack I, Clanget C, Ding R, et al. Assessment of levothyroxine sodium bioavailability. Clin Pharmacokinet 2004;43:1037-53
  • Bach-Huynh TG, Nayak B, Loh J, et al. Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab 2009;94:3905-12
  • Virili C, Bassotti G, Santaguida MG, et al. Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab 2012;97:E419-22
  • Asik M, Gunes F, Binnetoglu E, et al. Decrease in TSH levels after lactose restriction in Hashimoto’s thyroiditis patients with lactose intolerance. Endocrine 2013. [ Epub ahead of print]
  • Liwampo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab 2009;23:781-92
  • Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 2010;11:41-50
  • Lilja JJ, Laitinen K, Neuvonen PJ. Effects of grapefruit juice on the absorption of levothyroxine. Br J Clin Pharmacol 2005;60:337-41
  • Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of coffee caused by coffee. Thyroid 2008;18:293-301
  • Sachmechi I, Reich DM, Aninyei M, et al. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract 2007;13:345-9
  • Benvenga S, Ruggeri RM, Trimarchi F. Thyroid and drugs. In: Monaco F, editors. Thyroid Diseases. CRC Press; Boca Raton, FL: 2012. p. 482-3
  • Patanè S, Marte F. Acute myocardial infarction during L-thyroxine therapy in a patient with intermittent changing axis deviation, permanent atrial fibrillation and without significant coronary stenoses. Int J Cardiol 2010;138:e8-11
  • Peterson RE. The influence of the thyroid on adrenal cortical function. J Clin Invest 1958;37:736-43
  • Raghavan S, DiMartino-Nardi J, Saenger P, et al. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997;130:478-80
  • Nourbakhsh A, Ahmed HA, McAuliffe TB, et al. Case report: bilateral slipped capital femoral epiphyses and hormone replacement. Clin Orthop Relat Res 2008;466:743-8
  • Tsutaoka BT, Kim S, Santucci S. Seizure in a child after an acute ingestion of levothyroxine. Pediatr Emerg Care 2005;21:857-9
  • A booklet for patients and their families. A publication of the American Thyroid Association (ATA). 2013. Available from: http://www.thyroid.org/wp-content/uploads/patients/brochures/hypothyroidism_web_booklet.pdf [Last Accessed 9 February 2014]
  • Tönjes A, Karger S, Koch CA, et al. Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies. Thyroid 2006;16:1047-51
  • Anderson L, Joseph F, Goenka N, et al. Isolated thyroxine malabsorption treated with intramuscular thyroxine injections. Am J Med Sci 2009;337:150-2
  • Torres MS, Emerson CH. Myxedema coma. In: Irwin RS, Rippe JM, editors. Irwin & Rippe’s intensive care medicine. 7th edition. Lippincott Williams and Wilkins, Philadelphia, PA; 2011. p. 1055-8
  • Colucci P, D’Angelo P, Mautone G, et al. Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions. Ther Drug Monit 2011;33:355-61
  • Pabla D, Akhlaghi F, Zia H. A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharm 2009;72:105-10
  • Benvenga S, Ducharme MP. Effect of proton pump inhibitors (PPIs) on the relative bioavailability of levothyroxine (L-T4) in soft gel capsules and in tablets. Program and Abstract book of the 82nd Annual Meeting of the American Thyroid Association; 19-23 September 2012; Quebec City, Canada. Thyroid 2012;22(S1):A50
  • Vita R, Benvenga S. Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor: a problem that was solved by switching to L-T4 in soft gel capsule. Endocr Pract 2014;Mar;1;20(3):e38-41
  • Vita R, Saraceno G, Trimarchi F, Benvenga S. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 2013;43:154-60
  • De Grazia S, Carlomagno G, Unfer V, et al. Myo-inositol soft gel capsules may prevent the risk of coffee-induced neural tube defects. Expert Opin Drug Deliv 2012;9:1033-9
  • Santaguida M, Virili C, Gatto I, et al. A novel therapeutic approach for patients with gastric disorders and T4 malabsorption: thyroxine softgel preparation. Thyroid 2013;23(S1):A53
  • Cassio A, Monti S, Rizzello A, et al. Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J Pediatr 2013;162:1264-9
  • O’Leary CM, Nassar N, Zubrick SR, et al. Evidence of a complex association between dose, pattern and timing of prenatal alcohol exposure and child behaviour problems. Addiction 2010;105:74-86
  • Bernareggi A, Grata E, Pinorini MT, et al. Oral liquid formulation of Levothyroxine is stable in breakfast and may improve thyroid patient compliance. Pharmaceutics 2013;5:621-33
  • Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung 2012;62:631-6
  • Cappelli C, Pirola I, Gandossi E, et al. Oral liquid levothyroxine treatment at breakfast: a mistake? Eur J Endocrinol 2013;170:95-9
  • Le Traon G, Burgaud S, Horspool LJ. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium. J Vet Pharmacol Therap 2008;31:95-101
  • Peroni E, Vigone MC, Mora S, et al. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr 2014;81:50-4
  • Brancato D, Scorsone A, Saura G, et al. Comparison of TSH levels with liquid formulation versus tablet formulations of levothyroxine in the treatment of adult hypothyroidism. Endocr Pract2014. [ Epub ahead of print]
  • Vita R, Saraceno G, Trimarchi F, et al. A novel formulation of levothyroxine (oral solution) is resistant to the levothyroxine malabsorption induced by proton-pump inhibitors (PPI). Thyroid 2013;23(S1):A-71
  • Pirola I, Formenti AM, Gandossi E, et al. Oral liquid L-thyroxine (L-T4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg 2013;23:1493-6
  • Benvenga S. When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes 2013;20:467-
  • Boelaert K. Thyroid dysfunction in the elderly. Nat Rev Endocrinol 2013;9:194-204
  • Le Couteur DG, Hilmer SN, Glasgow N, et al. Prescribing in older people. Aust Fam Physician 2004;33:777-81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.